Extrinsic apoptosis pathway
The term apoptosis was first proposed by Kerr, Wyllie, and Currie in 1972, who suggested a mechanism of programmed cell deletion complementary to mitosis that regulates animal cell cell populations [19,20]. Since then, several other types of programmed cell deaths such as pyroptosis and necroptosis have been defined [7,44]. However, apoptosis is the most studied type of programmed cell death.
Apoptosis is important for maintaining cellular homeostasis and plays critically important roles during developmental and disease processes, especially in cancer and neurodegenerative diseases. Apoptosis occurs via two path- ways, that is intrinsic and extrinsic pathways [41]. Intrinsic apoptosis is initiated by cellular stress, such as that caused by critical DNA damage, and occurs via the mitochondrial pathway, whereas extrinsic apoptosis is initiated by extracellular death signals and does not require mitochondrial pathway activation [17].
Extrinsic apoptosis is triggered when death receptors are bound by specific ligands. These receptors are members of the tumor necrosis factor (TNF) receptor superfamily, which contains tumor necrosis factor (TNF) receptor-1, CD95 (Apo- 1 and Fas), DR4, and DR5 (TRAIL-R1 and -R2) and are characterized by a similar cytokine-rich extracellular domain. One example of the ligand binding death receptors is provided by binding between Fas ligands and Fas receptors. Examples of FasL/FasR and TNF-α/TNFR1 pathways are provided in Fig. 1 [1, 38, 43]. This ligand binding at death receptors leads to caspase activation, which eventually leads to apoptosis [41].
Fig. 1. Extrinsic apoptosis signaling pathway. In this schematic, the death receptor is Fas or TRAIL receptor. The ligands of Fas and TRAIL receptor are Fas ligand and TRAIL. Other death receptors follow more complex pathways. Ligands bind to death receptor and the cytosolic death domain of death receptor binds to the death domain of FADD. The death effector domain of FADD then interacts with the death effector domain of procaspase-8, and FADD bound procaspase-8 is processed by auto proteolysis to activated caspase-8, which activates procaspase-3 and leads to apoptosis.
Features of Caspase-8
Caspases are a family of cysteine proteases, which cleave substrates at aspartic acid residues, from which the term “caspase” was derived [33]. Caspases are divided into inflammatory caspases which include caspase-1, -4, and -5, and apoptotic caspases like caspase-2, -3, -6, -7, -8, -9, and -10 (Table 1) [5,28]. The apoptotic caspases are vital mediators of apoptosis and are classified as initiator or executioner caspases. Caspase-8 (also known as FLICE) is an initiator caspase [2,7], and when active activates effector caspases. Caspase-8 functions primarily in the extrinsic apoptotic pathway [39] but has also been shown to play roles in several non-apoptotic processes [27].
Table 1. Classification of caspases
Depending on function, caspases are classified apoptosis caspases and inflammation caspases. And Apoptosis caspases divided two types: Initiator caspases and Executioner caspases. Initiator caspases can activate executioner caspases. All caspases entered are human caspases.
As its name implies, procaspase-8 is a precursor of cas- pase-8, and is 55 kDa long and possesses two DEDs which are pro-domain at its N-terminal and C-terminal two proteolytic domains. And two proteolytic domains are composed of large subunit p18 and small subunit p12 [26](Fig. 2A). Caspase-8 is complexed with zymogen in cytosol [22], but during apoptosis, caspase-8 is sequentially activated by proteolysis at aspartic acid residues.
Fig. 2. Structural analysis of FADD, caspase-8, and c-FLIP. Domain structures of FADD, caspase-8, c-FLIPL, c-FLIPs, and c-FLIPR. FADD consists of DED and DD. (A) Caspase-8 and c-FLIPL each possess tandem DEDs and two catalytic domains. c-FLIPS and c-FLIPR both consist of a tandem DED and a short tail domain. (B) The dimeric structure of the tandem DED of caspase-8 (residues 1-188; PDB ID: 4ZBW). (C) The interaction between c-FLIPL and caspase-8. The two proteins bind each other’s catalytic domains (residues c-FLIPL: 209-480, caspase-8: 217-479; PDB ID: 3H11).
Mature caspase-8 is a heterotetramer consisting of two large subunits and two small subunits generated from two separate procaspase-8 molecules. Activation of procaspase-8 is initiated by its separation into large and small subunits, which is followed by separation of the large subunit and its prodomain [3,46].
Structure analysis DISC formation
Extrinsic apoptosis is initiated by the formation of death receptor-FADD-caspase-8 complex (DISC) as a result of extracellular stimulation (Fig. 1), and all three of these components of DISC are essential for its activity [30]. Although DISC formation also depends on death receptor, in this review we describe the FasL/FasR and TNF-α/TNFR1 models [31].
The first step of DISC formation involves death receptor activation, which is induced by its binding a receptor-specific ligand. After ligand binding, activated death receptor recruits other death receptors to form a homotrimer.
In the second step, the trimerized death receptors recruit the adapter protein FADD, which is a cytosolic adaptor protein essential for apoptotic signaling by death receptors. FADD has two highly conserved domains, that is, an N-ter- minal DED and a C-terminal DD [2](Fig. 2A). The DDs of death receptors and FADD are homotypic proteins that bind together in cytosol. The DDs of death receptor are cytoplasmic domains composed of about 80 amino acids that play key roles in the transmission of death signals from cell surfaces to intracellular signaling pathways [7]. When FADD binds to trimerized death receptor it causes a conformational change that exposes its DED, which binds caspase-8 [14,23].
The third step involves the recruitment of procaspase-8 by the DED of FADD and their interaction. Procaspase-8 binds to the exposed DED of death receptor-associated FADD through a pocket in its first DED to form DISC. Oligomerization then ensues via an interaction between a pocket in the second DED of the first caspase-8 and the first DED of the second caspase-8 molecule. This process continues with successive interactions to produce filaments [6,10]. Finally, cleavage of these filaments stabilizes and releases active caspase-8 dimers into the cytosol, which initiate apoptosis by processing target proteins [18,42].
During the process of procaspases dimerization, procas- pase-8 undergoes a conformational change and forms an active center of procaspase-8a/b, which is auto-catalytically cleaved by proteolysis to produce the active caspase-8 heterotetramer 2p10 and 2p18 [12].
In an investigation of the structure of the tandem DED of caspase-8, researchers demonstrated the dimeric structure of two caspase-8 tandem DED domains (Fig. 2B). The DEDs of the caspase-8 N-terminal were found to compose an α helical fold, in which they were closely associated with each other to form a dumbbell-shaped structure. The crystal structure of caspase-8 DEDs was solved as a dimer in the asymmetric unit. The proteolytic domain of the C-terminal of cas- pase-8 is composed of six β strands and five α helices [35] (Fig. 2C).
Therefore, in extrinsic apoptosis pathway, procaspase-8 dimerization and filamentation are important process to progress the apoptotic pathway. Thus, mutation of DEDs of procaspase-8 can affect procaspase-8 dimerization and formation of filament. Mutations inhibiting the dimerization of the DEDs such as F122A/I128D or F122A/N168R mutations prevent the dimerization and formation of cellular death effector filaments (DEFs) and the induced apoptosis by over expressed DEDs. In addition, these mutations also hinder the activation of the procaspase-8 and the downstream apoptosis cascade [34].
c-FLIP regulates caspase-8 activation
c-FLIP is a central regulator of the extrinsic apoptosis pathway and determines the activity of caspase-8 [16, 32, 40]. c-FLIP has three splice forms: a long splice form FLIPL and two short splice forms FLIPS and FLIPR. [11,15]. The sizes of these proteins are 55 kDa for FLIPL, 27 kDa for FLIPS, and 25 kDa for FLIPR. [29].
Caspase-8 and c-FLIPL have similar structures and domains, namely, two DEDs and two proteolytic domains [26] (Fig. 2A). The major difference between c-FLIPL and procas- pase-8 is the lack of proteolytic activity of c-FLIPL due to the absence of a catalytic cysteine in its large subunit. The two short forms c-FLIPS and c-FLIPR only contain a tandem DED and a short C-terminal tail. Therefore, all c-FLIP isoforms contain tandem DED that is structurally similar to tandem DED of procaspase-8. Short form FLIPs do not have a proteolytic domain, and thus, lack proteolytic activity [41].
The functions of c-FLIP isoforms differ. Short form c- FLIPs block caspase-8 activation by inhibiting the procas- pase-8 chains of DISC. These isoforms integrate into DED chains and block caspase-8 activation by forming inactive heterodimers [12]. On the other hand, c-FLIPL in DISC can act anti- or pro-apoptotically [4,21]. c-FLIPL functions like c-FLIPS and FLIPR when expressed at high concentrations intracellularly but at moderate concentrations facilitates the activation of procaspase-8 in DISC [29]. When c-FLIPL acts pro-apoptotically, it is cleaved by procaspase-8 and processed caspase-8, and the then processed c-FLIP facilitates the activation of caspase-8 and enhances the heterodimerization of c-FLIP and caspase-8. The interaction between the catalytic domain of c-FLIPL and caspase-8 is shown in Fig. 2C [16,24].
Recently, electron microscopy showed that when c-FLIPs is inserted into DISC, it inhibits caspase-8 activity due to steric hindrance of the canonical tandem DED Type I binding site. Thus, c-FLIPs prevents caspase-8 catalytic domain assembly and tandem DED helical filament elongation [8].
Active caspase-8 activates executioner caspases
Caspase-3 is the most important executioner caspase and is activated by any of the initiator caspases. Procaspase-3 exists dimeric in cytosol and have N-terminal short pro domain and C-terminal two catalytic domains. Caspase-8 can directly activate procaspase-3 by cleaving the prodomain of procaspase-3 [36]. These caspase cascades amplify apoptotic signaling and make the executioner caspase complete the apoptosis process [5]. Caspase-3 is important for DNA deg- radation, nuclear condensation, plasma membrane blebbing, and the proteolysis of certain caspase substrates [35]. Full activation of caspase-3 leads to cell death [17].
Non-apoptotic roles of caspase-8
Caspase-8 functions not only apoptosis but also other programmed cell death process such as necroptosis or pyroptosis. Many studies demonstrated that when the cas- pase-8 defective conditions, necroptosis and pyroptosis occur [9,41]. In necroptosis, programmed necrotic cell death, caspase-8 hindered necroptosis by preventing assemble the necrosome [23]. Like extrinsic apoptosis, necroptosis can be initiated by receptors such as TNFR or Fas. Necroptosis can occur upon activation of death receptors by specific receptors in the absence of caspase-8 activation [12].
Pyroptosis is an inflammatory form of programmed cell death that relies on the enzymatic activity of caspase-1 [44]. In pyroptosis pathway, caspase-8 is also concerned with the process. Extrinsic apoptosis triggers can lead to GSDMD cleavage and subsequent pyroptosis-like cell death in macrophages of Murine, which is mediated by the caspase-8 [12].
Conclusion
The extrinsic apoptosis pathway is regulated by extracellular stimuli and consequent DISC formation. Caspase- 8, an important mediator of extrinsic apoptosis, is a component of DISC, and its tandem DEDs are importantly required for this process. FADD recruits the DED of a caspase-8 molecule and the second DED of this molecule binds the first DED of a second caspase-8, and this oligomerization proceeds to form a filament structure. Activated caspase-8 converts other caspases and itself into executioner caspases.
c-FLIP can function in both anti- and pro-apoptotic ways. c-FLIPs and c-FLIPr block caspase-8 activation by interacting with the chains of procaspase-8, whereas c-FLIPL inhibits the activation of caspase-8 at high concentrations but facilitates its activation at moderate concentrations. When activated caspase-8 activates executioner caspases, cells are committed to apoptosis.
Acknowledgement
This work was supported by a 2-Year Research Grant from Pusan National University (2021-2022).
The Conflict of Interest Statement
The authors declare that they have no conflicts of interest with the contents of this article.
References
- Ashkenazi, A. and Dixit, V. M. 1998. Death receptors: signaling and modulation. Science 281, 1305-1308. https://doi.org/10.1126/science.281.5381.1305
- Barnhart, B. C., Lee, J. C., Alappat, E. C. and Peter, M. E. 2003. The death effector domain protein family. Oncogene 22, 8634-8644. https://doi.org/10.1038/sj.onc.1207103
- Chang, D. W., Xing, Z., Capacio, V. L., Peter, M. E. and Yang, X. 2003. Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22, 4132-4142. https://doi.org/10.1093/emboj/cdg414
- Chang, D. W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B. C., Yaish-Ohad, S. and Yang, X. 2002. c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21, 3704-3714. https://doi.org/10.1093/emboj/cdf356
- Degterev, A., Boyce, M. and Yuan, J. 2003. A decade of caspases. Oncogene 22, 8543-8567. https://doi.org/10.1038/sj.onc.1207107
- Dickens, L. S., Boyd, R. S., Jukes-Jones, R., Hughes, M. A., Robinson, G. L., Fairall, L. and MacFarlane, M. 2012. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol. Cell 47, 291-305. https://doi.org/10.1016/j.molcel.2012.05.004
- Elmore, S. 2007. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516. https://doi.org/10.1080/01926230701320337
- Fox, J. L., Hughes, M. A., Meng, X., Sarnowska, N. A., Powley, I. R., Jukes-Jones, R. and MacFarlane, M. 2021. Cryo-EM structural analysis of FADD: Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate. Nat. Commun. 12, 1-17. https://doi.org/10.1038/s41467-020-20314-w
- Fritsch, M., Gunther, S. D., Schwarzer, R., Albert, M. C., Schorn, F., Werthenbach, J. P. and Kashkar, H. 2019. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575, 683-687. https://doi.org/10.1038/s41586-019-1770-6
- Fu, T. M., Li, Y., Lu, A., Li, Z., Vajjhala, P. R., Cruz, A. C. and Wu, H. 2016. Cryo-EM structure of caspase-8 tandem DED filament reveals assembly and regulation mechanisms of the death-inducing signaling complex. Mol. Cell 64, 236-250. https://doi.org/10.1016/j.molcel.2016.09.009
- Golks, A., Brenner, D., Fritsch, C., Krammer, P. H. and Lavrik, I. N. 2005. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 280, 14507-14513. https://doi.org/10.1074/jbc.M414425200
- Gram, A. M., Booty, L. M. and Bryant, C. E. 2019. Chopping GSDMD: caspase-8 has joined the team of pyroptosis-mediating caspases. EMBO J. 38, e102065.
- Hillert, L. K., Ivanisenko, N. V., Busse, D., Espe, J., Konig, C., Peltek, S. E. and Lavrik, I. N. 2020. Dissecting DISC regulation via pharmacological targeting of caspase-8/c-FLIP L heterodimer. Cell Death Differ. 27, 2117-2130. https://doi.org/10.1038/s41418-020-0489-0
- Hughes, M. A., Powley, I. R., Jukes-Jones, R., Horn, S., Feoktistova, M., Fairall, L. and MacFarlane, M. 2016. Co-operative and hierarchical binding of c-FLIP and caspase-8: a unified model defines how c-FLIP isoforms differentially control cell fate. Mol. Cell 61, 834-849. https://doi.org/10.1016/j.molcel.2016.02.023
- Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V. and Tschopp, J. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195. https://doi.org/10.1038/40657
- Jong, W. Y., Jeffrey, P. D. and Shi, Y. 2009. Mechanism of procaspase-8 activation by c-FLIPL. Proc. Natl. Acad. Sci. USA. 106, 8169-8174. https://doi.org/10.1073/pnas.0812453106
- Kantari, C. and Walczak, H. 2011. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim. Biophys. Acta Mol. Cell. Res. 1813, 558-563. https://doi.org/10.1016/j.bbamcr.2011.01.026
- Keller, N., Mares, J., Zerbe, O. and Grutter, M. G. 2009. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. Structure 17, 438-448. https://doi.org/10.1016/j.str.2008.12.019
- Kerr, J. F. 2002. History of the events leading to the formulation of the apoptosis concept. Toxicology 181, 471-474. https://doi.org/10.1016/S0300-483X(02)00457-2
- Kerr, J. F., Wyllie, A. H. and Currie, A. R. 1972. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br. J. Cancer 26, 239-257. https://doi.org/10.1038/bjc.1972.33
- Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. and Kirchhoff, S. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276, 20633-20640. https://doi.org/10.1074/jbc.M101780200
- Kruidering, M. and Evan, G. I. 2000. Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 50, 85-90. https://doi.org/10.1080/713803693
- Linkermann, A. and Green, D. R. 2014. Necroptosis. N. Engl. J. Med. 370, 455-465. https://doi.org/10.1056/NEJMra1310050
- Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H. and Peter, M. E. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804. https://doi.org/10.1093/emboj/16.10.2794
- Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W. and Grutter, M. G. 2002. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162-45171. https://doi.org/10.1074/jbc.M206882200
- Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J. and Dixit, V. M. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827. https://doi.org/10.1016/S0092-8674(00)81266-0
- Oberst, A. and Green, D. R. 2011. It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 12, 757-763. https://doi.org/10.1038/nrm3214
- Orning, P. and Lien, E. 2021. Multiple roles of caspase-8 in cell death, inflammation, and innate immunity. J. Leukoc. Biol. 109, 121-141. https://doi.org/10.1002/JLB.3MR0420-305R
- Ozturk, S., Schleich, K. and Lavrik, I. N. 2012. Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp. Cell. Res. 318, 1324-1331. https://doi.org/10.1016/j.yexcr.2012.01.019
- Peter, M. E. 2000. The TRAIL DISCussion: It is FADD and caspase-8!. Cell Death Differ. 7, 759-760. https://doi.org/10.1038/sj/cdd/4400735
- Raducka-Jaszul, O., Boguslawska, D. M., Jedruchniewicz, N. and Sikorski, A. F. 2020. Role of extrinsic apoptotic signaling pathway during definitive erythropoiesis in normal patients and in patients with β-thalassemia. Int. J. Mol. Sci. 21, 3325. https://doi.org/10.3390/ijms21093325
- Schleich, K., Buchbinder, J. H., Pietkiewicz, S., Kahne, T., Warnken, U., Ozturk, S. and Lavrik, I. N. 2016. Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain. Cell Death Differ. 23, 681-694. https://doi.org/10.1038/cdd.2015.137
- Seaman, J. E., Julien, O., Lee, P. S., Rettenmaier, T. J., Thomsen, N. D. and Wells, J. A. 2016. Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues. Cell Death Differ. 23, 1717-1726. https://doi.org/10.1038/cdd.2016.62
- Shen, C., Pei, J., Guo, X., Zhou, L., Li, Q. and Quan, J. 2018. Structural basis for dimerization of the death effector domain of the F122A mutant of Caspase-8. Sci. Rep. 8, 1-10.
- Shen, C., Yue, H., Pei, J., Guo, X., Wang, T. and Quan, J. M. 2015. Crystal structure of the death effector domains of caspase-8. Biochem. Biophys. Res. Commun. 463, 297-302. https://doi.org/10.1016/j.bbrc.2015.05.054
- Slee, E. A., Adrain, C. and Martin, S. J. 2001. Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326. https://doi.org/10.1074/jbc.M008363200
- Stennicke, H. R., Jurgensmeier, J. M., Shin, H., Deveraux, Q., Wolf, B. B., Yang, X. and Salvesen, G. S. 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273, 27084-27090. https://doi.org/10.1074/jbc.273.42.27084
- Suliman, A., Lam, A., Datta, R. and Srivastava, R. K. 2001. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and-independent pathways. Oncogene 20, 2122-2133. https://doi.org/10.1038/sj/onc/1204282
- Sun, S. Y. 2011. Understanding the role of the death receptor 5/FADD/caspase-8 death signaling in cancer metastasis. Mol. Cell. Pharmacol. 3, 31.
- Tsuchiya, Y., Nakabayashi, O. and Nakano, H. 2015. FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP. Int. J. Mol. Sci. 16, 30321-30341. https://doi.org/10.3390/ijms161226232
- Tummers, B. and Green, D. R. 2017. Caspase-8: regulating life and death. Immunol. Rev. 277, 76-89. https://doi.org/10.1111/imr.12541
- Tummers, B., Mari, L., Guy, C. S., Heckmann, B. L., Rodriguez, D. A., Ruhl, S. and Green, D. R. 2020. Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis. Immunity 52, 994-1006. https://doi.org/10.1016/j.immuni.2020.04.010
- Wajant, H. 2002. The Fas signaling pathway: more than a paradigm. Science 296, 1635-1636. https://doi.org/10.1126/science.1071553
- Walle, L. V. and Lamkanfi, M. 2016. Pyroptosis. Curr. Biol. 26, R568-R572. https://doi.org/10.1016/j.cub.2016.02.019
- Yan, G., Elbadawi, M. and Efferth, T. 2020. Multiple cell death modalities and their key features. World Acad. Sci. J. 2, 39-48.
- Zhao, Y., Sui, X. and Ren, H. 2010. From procaspase-8 to caspase-8: Revisiting structural functions of caspase-8. J. Cell. Physiol. 225, 316-320. https://doi.org/10.1002/jcp.22276